The ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. Growth in this market is mainly driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology. On the other hand, high implementation and maintenance costs are expected to limit market growth during the forecast period. Poor compatibility with informatics standards may also challenge market growth to a certain extent.

Carl Zeiss Meditec AG is a leading player in the ophthalmology PACS market. The leading position of the company is attributed to its brand recognition and its innovative quality products. The company focuses on incorporating advanced technologies with its ophthalmology product offerings that make it a key player in this market. Additionally, the company has a strong presence across the globe through a diversified distribution network. Carl Zeiss continues to further strengthen its technological competence and geographic reach through acquisitions and partnerships. The company’s Center for Application and Research in Bangalore (India) and the Carl Zeiss Innovations Center for Research and Development in Shanghai (China) strengthened its presence in the rapidly developing economies of the APAC region. In addition, the company focuses on digitalization and system integration in ophthalmology, for that it continuously invests in R&D activities to introduce digital technologies in the market.

Topcon Corporation is a prominent player in this market. The company has maintained its leadership position in the market through its strong distribution networks across North America, Europe, and Asia Pacific (especially Japan and China). It focuses on product innovations and new product launches as its key business strategies to ensure growth in the global ophthalmology PACS market. In October 2016, the company launched its IMAGEnet Connect. The company also acquired 50.1% shares of ifa Systems AG (Germany), a provider of ophthalmology PACS systems. This acquisition enabled the company to enhance its existing product offerings and strengthen its position in the ophthalmology PACS market.

Sonomed Escalon is another important player in this market. The company has robust product offerings in the field of ophthalmic imaging and image management systems. The company seeks to grow its ophthalmology PACS business by focusing on its existing products, developing new products, utilizing strategic partnerships, and acquisitions. Its focus on showcasing its products in various conferences and seminars enables the company to enhance its customer base and thus maintain its leading position in the market.